Report: Mylan, Pfizer unit close to merger
July 27, 2019 at 16:23 PM EDT
Mylan (Nasdaq: MYL) and the off-patent medicine business of Pfizer (NYSE: PFE) would be combined to create a new entity that would be headquartered in the United States, according to the Journal.
